Cytek Bio (CTKB): Bathi resik saben saham (EPS TTM)

Cytek Biosciences, Inc. (CTKB) is recognized as an impeccable technological authority in cellular diagnostics. The rolling earnings per share trend confirms this status, where the -0.63 metric determines the status of the yield parameter. The company generates revenue through the sale of spectral cytometers and associated reagents. Income is based on the creation of innovative analysis systems for medical laboratories and pharmaceutical development.

CTKB Bathi resik saben saham sajrone patang kuartal pungkasan Cytek Corp (04.07.2022 - 11.11.2026)

Rincian analitis lan laporan data perusahaan Cytek Biosciences Inc (CTKB)

- kuotasi saiki lan rata-rata prakiraan nilai:

Bagan rega Cytek Biosciences, Inc.|CTKB - Target median analis

- data kapitalisasi bursa:

Kapitalisasi pasar Cytek Biosciences, Inc.|CTKB - Rega Tumbas Perusahaan

- rincian valuasi buku bisnis:

Aset Bersih saben Siji Saham Cytek Biosciences|CTKB - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku cytekbio.com|CTKB - Gunggung Aset Perusahaan

- indikator beban kredit lan likuiditas emiten:

Rasio Total Utang marang Ekuitas Cytek Biosciences, Inc.|CTKB - Kewajiban jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Cytek Bio|CTKB - Tanggungan utang kumulatif perusahaan|Utang-utang marang kapitalisasi buku Cytek Biosciences, Inc.|CTKB - Utang jangka dawa|Utang jangka cendhak perusahaan Cytek Biosciences|Indikator likuiditas cepet cytekbio.com

- data bathi lan kelipatan valuasi:

CTKB - Bathi pungkasan|Proyeksi bathi mangsa ngarep Cytek Biosciences, Inc.|CTKB - Rasio rega marang bathi|Pangali Forward P/E Cytek Biosciences|CTKB - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Cytek Biosciences, Inc.|CTKB - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Cytek Biosciences|CTKB - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan cytekbio.com|CTKB - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep Cytek Biosciences, Inc.

Ringkesan analitik perusahaan:Cytek Biosciences, Inc. (CTKB)

This indicator reflects the trailing twelve-month net income divided by the total number of shares, allowing for an assessment of the actual return on each share of ownership. The trend in the 12-month per-share net income of Cytek Biosciences, Inc. (CTKB) demonstrates capital sensitivity to specialized medical logistics and equipment calibration costs, directly impacting the final asset management efficiency of Cytek Biosciences, Inc. (CTKB).

Pesaing utama